+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Rheumatoid Arthritis"

From
From
Androgenetic Alopecia Treatment Market Report 2025 - Product Thumbnail Image

Androgenetic Alopecia Treatment Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Alopecia Market Report 2025 - Product Thumbnail Image

Alopecia Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Ankylosing Spondylitis Market Report 2025 - Product Thumbnail Image

Ankylosing Spondylitis Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
Rare Inflammatory Disease Treatment Market Report 2025 - Product Thumbnail Image

Rare Inflammatory Disease Treatment Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Autoimmune Disease Diagnosis Market Report 2025 - Product Thumbnail Image

Autoimmune Disease Diagnosis Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Systemic Lupus Erythematosus Treatment Market Report 2025 - Product Thumbnail Image

Systemic Lupus Erythematosus Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
Loading Indicator

Rheumatoid Arthritis (RA) is a chronic autoimmune disorder that affects the joints and other organs. It is a type of inflammatory arthritis that is caused by an overactive immune system. RA is a major cause of disability and is the most common form of inflammatory arthritis. It affects people of all ages, but is more common in women than men. Symptoms of RA include joint pain, swelling, stiffness, and decreased range of motion. Treatment for RA includes medications, physical therapy, and lifestyle changes. The RA market within the context of Allergy and Immunology is a rapidly growing market. It is driven by the increasing prevalence of RA, the development of new treatments, and the increasing demand for better treatments. The market is expected to grow due to the increasing awareness of RA and the increasing demand for better treatments. Some companies in the RA market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Roche. Show Less Read more